Paloma Partners Management Co boosted its holdings in shares of Express Scripts Holding (NASDAQ:ESRX) by 37.5% in the fourth quarter, HoldingsChannel reports. The firm owned 54,493 shares of the company’s stock after acquiring an additional 14,856 shares during the period. Paloma Partners Management Co’s holdings in Express Scripts were worth $4,068,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in the stock. Bank of New York Mellon Corp increased its stake in shares of Express Scripts by 8.7% in the 4th quarter. Bank of New York Mellon Corp now owns 8,287,905 shares of the company’s stock valued at $618,609,000 after buying an additional 666,754 shares during the period. Nordea Investment Management AB increased its stake in shares of Express Scripts by 2.6% in the 3rd quarter. Nordea Investment Management AB now owns 7,304,973 shares of the company’s stock valued at $462,551,000 after buying an additional 188,528 shares during the period. Geode Capital Management LLC increased its stake in shares of Express Scripts by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,608,383 shares of the company’s stock valued at $492,297,000 after buying an additional 32,548 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of Express Scripts by 1.3% in the 3rd quarter. Dimensional Fund Advisors LP now owns 6,545,076 shares of the company’s stock valued at $414,419,000 after buying an additional 86,800 shares during the period. Finally, Ameriprise Financial Inc. increased its stake in shares of Express Scripts by 23.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock valued at $331,374,000 after buying an additional 996,816 shares during the period. 89.08% of the stock is owned by hedge funds and other institutional investors.
In other Express Scripts news, VP Glen D. Stettin sold 3,448 shares of Express Scripts stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $76.00, for a total transaction of $262,048.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP Glen D. Stettin sold 3,449 shares of Express Scripts stock in a transaction dated Thursday, January 11th. The stock was sold at an average price of $81.00, for a total value of $279,369.00. Following the transaction, the vice president now owns 33,715 shares in the company, valued at $2,730,915. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 21,896 shares of company stock worth $1,617,903. Corporate insiders own 0.68% of the company’s stock.
ESRX has been the subject of several research reports. SunTrust Banks reissued a “buy” rating and issued a $95.00 target price on shares of Express Scripts in a research note on Friday, January 12th. Zacks Investment Research lowered Express Scripts from a “strong-buy” rating to a “hold” rating in a research report on Tuesday. Robert W. Baird upgraded Express Scripts from a “neutral” rating to an “outperform” rating and raised their price target for the stock from $72.00 to $81.00 in a research report on Friday, December 15th. William Blair lowered Express Scripts from an “outperform” rating to a “market perform” rating in a research report on Thursday, March 8th. Finally, Raymond James Financial restated a “sell” rating on shares of Express Scripts in a research report on Friday, December 15th. Three equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and seven have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $81.97.
Express Scripts Holding (ESRX) opened at $77.00 on Wednesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.55 and a current ratio of 0.67. The firm has a market capitalization of $43,916.79, a PE ratio of 9.83, a price-to-earnings-growth ratio of 0.96 and a beta of 0.94. Express Scripts Holding has a twelve month low of $55.80 and a twelve month high of $85.07.
Express Scripts (NASDAQ:ESRX) last posted its earnings results on Tuesday, February 27th. The company reported $2.16 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.09 by $0.07. The firm had revenue of $25.38 billion for the quarter, compared to analyst estimates of $25.07 billion. Express Scripts had a return on equity of 25.19% and a net margin of 4.51%. The company’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.88 earnings per share. equities analysts predict that Express Scripts Holding will post 9.35 EPS for the current year.
Express Scripts announced that its board has initiated a stock buyback plan on Monday, December 18th that permits the company to repurchase 45,000,000 outstanding shares. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.
WARNING: “Express Scripts Holding (ESRX) Position Raised by Paloma Partners Management Co” was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://ledgergazette.com/2018/03/14/express-scripts-holding-esrx-position-raised-by-paloma-partners-management-co.html.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.